After studying the influence of 13 EO compounds on the in vitro growth inhibition of members from the intestinal microbiota,
Ouwehand et al. (2006) found that beneficial microbes such as Lactobacilli and Bifidobacteria were less sensitive to EO antimicrobial effect than potentially pathogenic bacteria such as E. coli, C. perfringens and Salmonella.